Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

AGEs inhibition composite, application of AGEs inhibition composite, preparation method of AGEs inhibition composite, and AGEs inhibitor

A composition and inhibitor technology, applied in the field of health food, can solve problems such as adverse reactions and applications, and achieve the effects of reducing plasma protein binding, delaying diabetes, and reasonable formula

Active Publication Date: 2018-12-28
BY HEALTH CO LTD
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, aminoguanidine and its compounds have been found to have adverse reactions in clinical trials and cannot be used in clinical practice, so they have withdrawn from the stage of clinical research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • AGEs inhibition composite, application of AGEs inhibition composite, preparation method of AGEs inhibition composite, and AGEs inhibitor
  • AGEs inhibition composite, application of AGEs inhibition composite, preparation method of AGEs inhibition composite, and AGEs inhibitor
  • AGEs inhibition composite, application of AGEs inhibition composite, preparation method of AGEs inhibition composite, and AGEs inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Present embodiment formula is as follows:

[0052] Formulation of table 2 AGEs inhibition composition

[0053] Name of raw material

[0054] Preparation method: weigh and mix each raw material.

Embodiment 2

[0056] Present embodiment formula is as follows:

[0057] Formulation of table 3 AGEs inhibition composition

[0058]

[0059]

[0060] Preparation method: weigh and mix each raw material.

Embodiment 3

[0062] Present embodiment formula is as follows:

[0063] Formulation of table 4 AGEs inhibition composition

[0064] Name of raw material

[0065] Preparation method: weigh and mix each raw material.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of health foods, in particular to an AGEs inhibition composite, application of the AGEs inhibition composite, a preparation method of the AGEs inhibition composite, and an AGEs inhibitor. The AGEs inhibition composite is prepared from the following raw materials according to parts by weight: 25-500 parts of bilberry extracts, 15-110 parts of ginkgo biloba extracts, 25-125 parts of green tea extracts, 0.3-20 parts of rosemary extracts, 0.1-10 parts of vitamin B1, 0.1-10 parts of vitamin B2, and 0.1-10 parts of vitamin B6. The AGEs inhibition composite provided by the invention has the advantages that the formula is reasonable, that is, the bilberry extracts, the ginkgo biloba extracts, the green tea extracts, the rosemary extracts, the vitamin B1, the vitamin B2 and the vitamin B6 are combined to achieve remarkable synergetic effects in AGEs generation inhibition and AGEs degradation.

Description

technical field [0001] The invention relates to the technical field of health food, in particular to an AGEs inhibiting composition and its application, preparation method and preparation. Background technique [0002] Advanced glycation end products (AGEs) refer to the stable covalent addition of macromolecules such as proteins, lipids or nucleic acids that spontaneously react with glucose or other reducing monosaccharides without the participation of enzymes. into things. It is the end product of a non-enzymatic glycosylation reaction (Maillard reaction) and is the product of excess sugar and protein binding. Dozens of AGEs have been identified, such as carboxymethyllysine (CML), carboxyethyllysine (CEL), pyrrolidine and so on. Under pathological conditions, AGEs can exist in the corresponding diseased tissues. [0003] There are two sources of AGEs in the body, one is the synthesis of AGEs in the body from excess sugar and protein, and the other is the ingestion of AGE...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/105A23L33/15A61K36/82A61P3/10A61P9/10A61P13/12A61P1/16A61P25/28A61K31/525A61K31/51A61K31/4415
CPCA61P1/16A61P3/10A61P9/10A61P13/12A61P25/28A23L33/105A23L33/15A61K31/4415A61K31/51A61K31/525A61K36/16A61K36/45A61K36/53A61K36/82A61K2300/00
Inventor 贺瑞坤张旭光汪玉芳肖健林芸张铭辉
Owner BY HEALTH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com